Sort
21,281 grants matching “influenza”
GH16-006: Conducting Public Health Research in Kenya
$1,438,500Christopher D Bayer · Hjf Medical Research International, Inc. · U01 · FY2019 · GH
NOVEL CELLULAR AND VIRAL TARGETS FOR ANTI-INFLUENZA VIRUS DRUGS
$1,435,679Peter Palese · Icahn School Of Medicine At Mount Sinai · U01 · FY2009 · AI
Laboratory And Pre-clinical Studies Of Parainfluenza Viruses
$1,435,433Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
VACCINE ADJUVANT DISCOVERY PROGRAM (VADP)
$1,435,380Ofer Levy · Boston Children'S Hospital · N01 · FY2024 · AI
A Phase 1/2a, randomized study of a Tfh-targeting genetic vaccine adjuvant designed to induce broad, durable immune responses
$1,435,214Kara W Chew · University Of California Los Angeles · U01 · FY2024 · AI
GH13-003: Hospital - Based Surveillance of Acute Febrile Illness in Western Ghat Region of
$1,434,000Arunkumar Govindakarnavar · Manipal Academy Of Higher Education · U01 · FY2017 · GH
Innate Immunity and Viral Infection in Asthma
$1,433,547Monica Kraft · University Of Arizona · U19 · FY2021 · AI
Collaborative Influenza Vaccine Innovation Centers STATISTICAL, DATA MANAGEMENT AND COORDINATION CENTER (SDMCC)
$1,432,309Stephan Bour · Digital Infuzion, Inc. · N01 · FY2020 · AI
Innate Immunity and Viral Infection in Asthma
$1,431,641Monica Kraft · University Of Arizona · U19 · FY2023 · AI
Innate Immunity and Viral Infection in Asthma
$1,431,641Monica Kraft · University Of Arizona · U19 · FY2022 · AI
Innate Immunity and Viral Infection in Asthma
$1,431,641Monica Kraft · University Of Arizona · U19 · FY2024 · AI
Innate Immunity and Viral Infection in Asthma
$1,431,641Monica Kraft · University Of Arizona · U19 · FY2025 · AI
Human Mab Cocktails to Prevent & Treat H5N1 Avian Influenza
$1,430,391Wayne A. Marasco · Dana-Farber Cancer Inst · U01 · FY2011 · AI
Development of drugs that target the M2 proton channel from the influenza A Virus
$1,430,000William F Degrado · University Of Pennsylvania · U01 · FY2008 · AI
Collaborative Influenza Vaccine Innovation Centers STATISTICAL, DATA MANAGEMENT AND COORDINATION CENTER (SDMCC)
$1,429,508Stephan Bour · Digital Infuzion, Inc. · N01 · FY2019 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit
$1,427,717Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2024 · AI
Innate inflammatory responses during pulmonary infections
$1,427,583Katrin Mayer-Barber · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
NOVEL CELLULAR AND VIRAL TARGETS FOR ANTI-INFLUENZA VIRUS DRUGS
$1,427,583Peter Palese · Icahn School Of Medicine At Mount Sinai · U01 · FY2011 · AI
High-throughput identification of antibody features for sequence-based epitope prediction
$1,427,400Nicholas C. Wu · University Of Illinois At Urbana-Champaign · DP2 · FY2021 · AT
Preclinical development of semisynthetic saponin immunological adjuvant Titerquil-1055 in the context of an influenza vaccine
$1,427,022Tyler Martin · Adjuvance Technologies, Inc. · N43 · FY2019 · AI
SBIR Phase II: Stress Pathway Inhibition To Prevent COVID-19 Infection (COVID-19)
$1,427,000Donald J Davidson · Creative Biotherapeutics Llc · · FY2022 · TIP
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,425,978John Jay Treanor · University Of Rochester · N01 · FY2018 · AI
Discovery of novel synthetic IL-1 adjuvants
$1,425,708Jay Evans · University Of Montana · N01 · FY2019 · AI
Influenza Vaccine Development
$1,425,675Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Paramyxoviruses as Vaccine Vectors Against Highly Pathogenic Viruses
$1,425,149Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI